Literature DB >> 15819697

The role of macrophages in the in vitro generation of extracellular DNA from apoptotic and necrotic cells.

Jin-Jung Choi1, Charles F Reich, David S Pisetsky.   

Abstract

Cell death is a ubiquitous process that occurs by apoptosis or necrosis depending on the triggering event. While apoptotic and necrotic cells differ biochemically, both are cleared by macrophages for elimination. The process is very efficient, although DNA can appear in the blood in various clinical conditions associated with cell death. To define the role of macrophages in the generation of extracellular DNA, in vitro experiments were performed, assessing the release of DNA into the media of apoptotic or necrotic Jurkat cells cultured with RAW264.7 or J774 macrophage cell lines. DNA was measured by a fluorimetric assay using the dye PicoGreen. In these experiments, while necrotic cells alone did not release DNA, in the presence of macrophages, significant amounts of DNA appeared in the medium. This DNA contained sequences from the Jurkat cells and had reduced molecular weight in comparison to cellular DNA. Furthermore, coculture of macrophages with enucleated necrotic Jurkat cells did not release DNA, suggesting that the DNA came from the dead cell. In contrast, Jurkat cells made apoptotic by treatment with either staurosporine or etoposide spontaneously released DNA, while coculture with macrophages caused a decrease in the DNA released. With apoptotic cells, the DNA in the medium showed low molecular weight and laddering whether or not macrophages were present. Together, these results indicate that macrophages play an important role in the generation of extracellular DNA from dead and dying cells, with the effect dependent on how the cell died.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15819697      PMCID: PMC1782131          DOI: 10.1111/j.1365-2567.2005.02130.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  40 in total

Review 1.  Circulating nucleosomes in serum.

Authors:  S Holdenrieder; P Stieber; H Bodenmüller; M Busch; J Von Pawel; A Schalhorn; D Nagel; D Seidel
Journal:  Ann N Y Acad Sci       Date:  2001-09       Impact factor: 5.691

Review 2.  Nuclear apoptotic changes: an overview.

Authors:  A M Martelli; M Zweyer; R L Ochs; P L Tazzari; G Tabellini; P Narducci; R Bortul
Journal:  J Cell Biochem       Date:  2001       Impact factor: 4.429

Review 3.  Phagocyte receptors for apoptotic cells: recognition, uptake, and consequences.

Authors:  V A Fadok; D L Bratton; P M Henson
Journal:  J Clin Invest       Date:  2001-10       Impact factor: 14.808

4.  Efficient antitumor immunity derived from maturation of dendritic cells that had phagocytosed apoptotic/necrotic tumor cells.

Authors:  Z Chen; T Moyana; A Saxena; R Warrington; Z Jia; J Xiang
Journal:  Int J Cancer       Date:  2001-08-15       Impact factor: 7.396

5.  Clinical significance of plasma nucleosome levels in cancer patients.

Authors:  K Kuroi; C Tanaka; M Toi
Journal:  Int J Oncol       Date:  2001-07       Impact factor: 5.650

6.  Plasma levels of nucleosomes and nucleosome-autoantibody complexes in murine lupus: effects of disease progression and lipopolyssacharide administration.

Authors:  R Licht; M C van Bruggen; B Oppers-Walgreen; T P Rijke; J H Berden
Journal:  Arthritis Rheum       Date:  2001-06

7.  Complement binding is an early feature of necrotic and a rather late event during apoptotic cell death.

Authors:  U S Gaipl; S Kuenkele; R E Voll; T D Beyer; W Kolowos; P Heyder; J R Kalden; M Herrmann
Journal:  Cell Death Differ       Date:  2001-04       Impact factor: 15.828

8.  Plasma DNA, prediction and post-traumatic complications.

Authors:  T H Rainer
Journal:  Clin Chim Acta       Date:  2001-11       Impact factor: 3.786

9.  Nonphlogistic clearance of late apoptotic neutrophils by macrophages: efficient phagocytosis independent of beta 2 integrins.

Authors:  Y Ren; L Stuart; F P Lindberg; A R Rosenkranz; Y Chen; T N Mayadas; J Savill
Journal:  J Immunol       Date:  2001-04-01       Impact factor: 5.422

Review 10.  Immune responses to DNA in normal and aberrant immunity.

Authors:  D S Pisetsky
Journal:  Immunol Res       Date:  2000       Impact factor: 4.505

View more
  67 in total

Review 1.  HMGB1 and microparticles as mediators of the immune response to cell death.

Authors:  David S Pisetsky; Julie Gauley; Anirudh J Ullal
Journal:  Antioxid Redox Signal       Date:  2011-05-05       Impact factor: 8.401

Review 2.  Nucleic acids in circulation: are they harmful to the host?

Authors:  Indraneel Mittra; Naveen Kumar Nair; Pradyumna Kumar Mishra
Journal:  J Biosci       Date:  2012-06       Impact factor: 1.826

Review 3.  Detection of Solid Tumor Molecular Residual Disease (MRD) Using Circulating Tumor DNA (ctDNA).

Authors:  Re-I Chin; Kevin Chen; Abul Usmani; Chanelle Chua; Peter K Harris; Michael S Binkley; Tej D Azad; Jonathan C Dudley; Aadel A Chaudhuri
Journal:  Mol Diagn Ther       Date:  2019-06       Impact factor: 4.074

4.  A prospective study of total plasma cell-free DNA as a predictive biomarker for response to systemic therapy in patients with advanced non-small-cell lung cancers.

Authors:  B T Li; A Drilon; M L Johnson; M Hsu; C S Sima; C McGinn; H Sugita; M G Kris; C G Azzoli
Journal:  Ann Oncol       Date:  2015-10-20       Impact factor: 32.976

Review 5.  Cell-free nucleic acids as biomarkers in cancer patients.

Authors:  Heidi Schwarzenbach; Dave S B Hoon; Klaus Pantel
Journal:  Nat Rev Cancer       Date:  2011-05-12       Impact factor: 60.716

6.  Detection of cancer DNA in plasma of patients with early-stage breast cancer.

Authors:  Julia A Beaver; Danijela Jelovac; Sasidharan Balukrishna; Rory Cochran; Sarah Croessmann; Daniel J Zabransky; Hong Yuen Wong; Patricia Valda Toro; Justin Cidado; Brian G Blair; David Chu; Timothy Burns; Michaela J Higgins; Vered Stearns; Lisa Jacobs; Mehran Habibi; Julie Lange; Paula J Hurley; Josh Lauring; Dustin VanDenBerg; Jill Kessler; Stacie Jeter; Michael L Samuels; Dianna Maar; Leslie Cope; Ashley Cimino-Mathews; Pedram Argani; Antonio C Wolff; Ben H Park
Journal:  Clin Cancer Res       Date:  2014-02-06       Impact factor: 12.531

Review 7.  Towards a pro-resolving concept in systemic lupus erythematosus.

Authors:  Sebastian Boeltz; Melanie Hagen; Jasmin Knopf; Aparna Mahajan; Maximilian Schick; Yi Zhao; Cornelia Erfurt-Berge; Jürgen Rech; Luis E Muñoz; Martin Herrmann
Journal:  Semin Immunopathol       Date:  2019-11-06       Impact factor: 9.623

8.  Detection and quantification of mutations in the plasma of patients with colorectal tumors.

Authors:  Frank Diehl; Meng Li; Devin Dressman; Yiping He; Dong Shen; Steve Szabo; Luis A Diaz; Steven N Goodman; Kerstin A David; Hartmut Juhl; Kenneth W Kinzler; Bert Vogelstein
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-28       Impact factor: 11.205

9.  Feasibility and clinical value of circulating tumor DNA testing in patients with gastric adenocarcinomas.

Authors:  Madiha Iqbal; Ali Roberts; Jason Starr; Kabir Mody; Pashtoon Murtaza Kasi
Journal:  J Gastrointest Oncol       Date:  2019-06

Review 10.  Predicting Radiotherapy Responses and Treatment Outcomes Through Analysis of Circulating Tumor DNA.

Authors:  Aadel A Chaudhuri; Michael S Binkley; Evan C Osmundson; Ash A Alizadeh; Maximilian Diehn
Journal:  Semin Radiat Oncol       Date:  2015-05-15       Impact factor: 5.934

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.